Brad Millman, MD
Otolaryngology · Yardley, PANPI 1316918360
Payments from drug & device makers
Across 63 payments — averaging $139.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Olympus America Inc.$8K
- Regeneron Healthcare Solutions, Inc.$346
- GSK$308
- Optinose US, Inc.$103
- Inspire Medical Systems, Inc.$72
- Kaleo, Inc.$60
- plus $182 from 7 others
What the payments were for
- Food & beverage$1,07112%
- Other$7,70088%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Olympus America Inc. | 1 | $7,700 |
| Regeneron Healthcare Solutions, Inc. | 20 | $346 |
| GSK | 16 | $308 |
| Optinose US, Inc. | 6 | $103 |
| Inspire Medical Systems, Inc. | 4 | $72 |
| Kaleo, Inc. | 4 | $60 |
| Phathom Pharmaceuticals, Inc. | 3 | $52 |
| Arbor Pharmaceuticals, Inc. | 3 | $36 |
| Medtronic | 2 | $29 |
| Alk-abello, Inc | 1 | $18 |
| Sanofi | 1 | $18 |
| Merck | 1 | $17 |
| Glenmark Therapeutics Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RHINO-LARYNGO FIBERSCOPE$7,700
How this compares
$8,771 in reported general payments places this provider in the 85th percentile of 456 otolaryngology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 949 | $8,588 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 118 | $5,994 |
| Famotidine | 649 | $5,462 |
| Sucralfate | 285 | $4,376 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 35 | $3,997 |
| Montelukast Sodium | 500 | $3,742 |
| Mupirocin | 184 | $2,015 |
| Fluocinolone Acetonide | 79 | $1,877 |
| Omeprazole | 133 | $1,479 |
| Ipratropium Bromide | 69 | $1,118 |
| Ofloxacin | 54 | $1,036 |
| CefuroximeCefuroxime Axetil | 96 | $1,002 |
| Prednisone | 360 | $799 |
| Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort | 15 | $768 |
| Azelastine Hcl | 46 | $513 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Yardley
- Nancy SnydermanPhiladelphia$4.5M
- Joseph CurryPhiladelphia$2M
- David YenBethlehem$2M
- Stella LeePittsburgh$825K
- John GermillerPhiladelphia$825K
- Adam LuginbuhlPhiladelphia$745K
- Neerav GoyalHershey$640K
- David KennedyPhiladelphia$603K
- Richard SterlingPhiladelphia$378K
- Mauritis BoonPhiladelphia$363K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.